Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 9
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02326974 T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA |
T-DM1 | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dana-Farber Cancer Institute | United States · Dana Farber Cancer Institute, Boston,… | 2015-01 → 2028-01 | Ouvrir |
| NCT05152147 HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherap… |
Zanidatamab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Jazz Pharmaceuticals | Argentina, Australia, Belgium, Brazil, Canada, Chile,… | 2021-12-02 → 2027-09-30 | Ouvrir |
| NCT06429761 STRIDE — Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, … |
Trastuzumab deruxtecan | Cancer | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | India · Research Site, Bangalore, India | Research Si… | 2025-01-02 → 2026-10-31 | Ouvrir |
| NCT06750484 Trial of Trastuzumab Deruxtecan in Previously Treated HER2 |
Trastuzumab deruxtecan | Cancer | Phase 2 | RECRUITING | En attente / non publié | AstraZeneca | United States · Emory Winship Cancer Institute, Atlan… | 2025-06-20 → 2028-12-31 | Ouvrir |
| NCT03615326 Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epide… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Brazil, Chile, China, Franc… | 2018-10-05 → 2025-11-12 | Ouvrir |
| NCT07543536 MEGA-TACT-BC3 — Megestrol Acetate for Fatigue Management in T-DXd Treat… |
Megestrol Acetate + Trastuzumab D… | Cancer | Phase 3 | RECRUITING | En attente / non publié | Sun Yat-sen University | China · Sun Yat-sen University Cancer Center, Guangzh… | 2026-06-08 → 2031-04-01 | Ouvrir |
| NCT05256225 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemot… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Puerto Rico, South Korea · Abbott-Nort… | 2022-11-16 → 2027-10-31 | Ouvrir |
| NCT06989112 DE-01 — DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxte… |
Trastuzumab deruxtecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Australia, Austria, Belgium, Brazil, C… | 2025-03-27 → 2031-02-19 | Ouvrir |
| NCT03014076 Immunotherapy Vaccine and Herceptin in Breast Cancer |
GP2 peptide + GM-CSF vaccine plus… | Cancer | Phase 1 | COMPLETED | En attente / non publié | Cancer Insight, LLC | Non communiqué | 2008-01 → 2017-01 | Ouvrir |